Redcare Pharmacy
(OTC) SHPPF
Redcare Pharmacy Financials at a Glance
Market Cap
$1.30BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
€3.08B
Net Income (TTM)
-€37.41M
EPS (TTM)
$0.00
P/E Ratio
-29.68
Dividend
$0.00
Beta (Volatility)
0.17 (Low)
Dividend
$0.00
Beta (Volatility)
0.17 (Low)
Price
$64.80
Volume
100
Open
$64.80
Price
$64.80
Volume
100
Open
$64.80
Previous Close
$64.80
Daily Range
$64.80 - $64.80
52-Week Range
$45.18 - $148.22
Estimated Earnings Date
Jul 29, 2026
Dividend
$0.00
Beta (Volatility)
0.17 (Low)
Price
$64.80
Volume
100
Open
$64.80
Previous Close
$64.80
Daily Range
$64.80 - $64.80
52-Week Range
$45.18 - $148.22
Estimated Earnings Date
Jul 29, 2026
SHPPF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Redcare Pharmacy
Industry
Food and Staples Retailing
Sector
Consumer StaplesEmployees
2,649
CEO
Olaf Heinrich
Website
www.redcare-pharmacy.comHeadquarters
Sevenum, LI 5975 WD, NL
SHPPF Financials
Key Financial Metrics (TTM)
Gross Margin
20.57%
Operating Margin
-0.75%
Net Income Margin
-1.22%
Return on Equity
-7.79%
Return on Capital
-2.72%
Return on Assets
-3.17%
Earnings Yield
-3.37%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.30BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
20.11M
Volume
100
Avg. Volume
1.629
Financials (TTM)
Gross Profit
€632.74M
Operating Income
-€23.17M
EBITDA
€69.77M
Operating Cash Flow
€10.93M
Capital Expenditure
-€100.62M
Free Cash Flow
-€89.69M
Cash & ST Invst.
€135.51M
Total Debt
€356.15M
Redcare Pharmacy Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
€852.73M
+18.9%
Gross Profit
€161.61M
-3.4%
Gross Margin
18.95%
N/A
Market Cap
$1.30BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$713.32K
N/A
Employees
1,827
N/A
Net Income
-€10.54M
+2.6%
EBITDA
€13.35M
+45.1%
Quarterly Fundamentals
Total Cash
€135.51M
-26.7%
Total Debt
€356.15M
+44.3%
Accounts Receivable
€156.99M
+35.1%
Inventory
€215.62M
+33.5%
Long Term Debt
€333.06M
+29.9%
Short Term Debt
€23.09M
+134.6%
Return on Assets
-3.17%
N/A
Return on Invested Capital
-2.88%
N/A
Free Cash Flow
€8.13M
-51.0%
Operating Cash Flow
€20.78M
-43.7%